Lab supply companies have been selling antibodies using manipulated images

A recent scientific investigation has uncovered widespread image manipulation within the promotional materials used by commercial laboratory suppliers.

Researcher Reese Richardson, alongside collaborator Sholto David, developed semi-automated testing methods to systematically analyze marketing images meant to demonstrate antibody performance. Their investigation revealed that nearly seven percent of the examined images showed clear signs of tampering. The detected issues ranged from the artificial removal of background noise to the outright copying and pasting of data to fabricate successful experimental outcomes. Ultimately, the duo identified issues with over 17,000 commercially available antibodies distributed across 16 different supply companies.

These findings carry severe practical consequences for the broader biological research community. Scientists frequently purchase pre-made antibodies expecting them to function as advertised in marketing materials like western blots. When these products fail to deliver clean data, researchers often assume the fault lies with their own laboratory techniques, leading them to squander significant time, effort, and funding trying to troubleshoot their processes. Meanwhile, the reaction from the targeted lab supply corporations has been underwhelming, ranging from vague assurances of future investigations to outright dismissals of the problem, leaving frustrated scientists to deal with the fallout of unreliable research materials.